Pipeline

NEUROSTECH proprietary technology enables the development of a robust Medical Device Pipeline for CNS controlled drug delivery systems and CSF management.

Our core solutions are implantable devices acting on the CSF

Based on our expertise in selective nonporous membranes and CSF flow dynamics, we are developing 4 devices acting on the CSF. The following pipeline chart shows products under active development.

CNS drug delivery

  • INVERLEASE: Proprietary fully implantable device for selective clearance of targeted molecules directly from the CSF.
  • CHRONOLEASE: Continuous release of drugs beyond the BBB: control at the nanometric scale for the sustained delivery of advance therapies.

CSF management

  • Extracorporeal Liquorpheresis: Advanced CSF filtration for the treatment of acute pathologies.

  • Intracorporeal Liquorpheresis: Smart & easy advanced lumbar CSF drainage for the treatment of subarachnoid hemorrhage.

How do we fight neurodegeneration?

INVERLEASE™ device

A fully implantable solution designed for pseudo-delivery of immunotherapies to treat neurodegenerative diseases.

Why choose our CSF filtration system?

Extracorporeal Catheter

Optimized catheters for extracorporeal CSF filtration (liquourpheresis) and lumbar drainage in acute, life-threatening conditions.

Our strategy includes multiple licensing opportunities across therapeutic areas, driven by regulatory approvals for monoclonal antibodies (mAbs), with robust geographical IP protection supporting global expansion.